Navigation Links
Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc
Date:8/5/2008

WHIPPANY, N.J., Aug. 5 /PRNewswire/ -- Nexgen Spine, a leading developer of innovative spinal implants for the surgical treatment of degenerative disc disease, announced today that it has received CE mark approval to market the Physio-L(R) Lumbar Artificial Disc in the European Union.

"We are delighted that the Physio-L(R) Artificial Disc Prosthesis has received CE mark approval," said Alastair Clemow, Ph.D., President and CEO of Nexgen Spine. "This represents an important milestone in our plan to launch a full range of artificial disc prostheses based on our proprietary elastomeric disc technology." Dr. Clemow further added, "the fact that the Physio-L(R) is the first of the next generation elastomeric lumbar discs to receive a CE mark makes this approval even more exciting."

The Physio-L(R) Artificial Disc is an elastomeric disc prosthesis designed to be used in the lumbar spine for patients suffering from degenerative disc disease. The device's proprietary elastomeric technology enables the disc to closely mimic the mechanical properties of the natural disc and represents a significant advance over current designs of disc prostheses.

"The unique properties of the Physio-L(R) help restore the natural shock absorption of the disc," said Casey Lee MD, Chairman and Founder of Nexgen Spine. "This allows the surgeon to restore function to the patient's disc. The clinical data for the Physio-L(R) are demonstrating outstanding improvements in both patient disability and pain, supporting the concept of using elastomeric polymers for total disc prostheses."

Nexgen Spine, Inc. is dedicated to providing its customers with high quality products that promote pain relief, preservation of motion and restoration of function by applying state-of-the-art design, biomaterials, and manufacturing technology. The company, based in Whippany NJ, is ISO 13485:2003 certified.

Contact: Alastair Clemow, President & CEO at 973-386-1800 ext 302 (aclemow@nexgenspine.com)


'/>"/>
SOURCE Nexgen Spine
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference
2. Impliant Launches Less-Invasive Version of Patented TOPS(TM) Spine System
3. Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
4. CoreSpine Technologies Expands Spinal Disc Site Preparation Efforts
5. SpineMark Partners With Regional Spine Leaders to Launch Its First Multisite Spine Research Organizations in Los Angeles, Denver
6. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
7. SpineSmith Partners to Present at 3rd Annual Stem Cell Summit
8. FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
9. Syndicom SpineConnect Web Platform Chosen for Applied Spines Leg and Back Pain Clinical Trial of Its Stabilimax NZ(R) Dynamic Spine Stabilization System
10. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
11. ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti-HIV Topical Microbicide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... The global  anxiety disorders and depression treatment market  is ... incidence of depression worldwide is anticipated to drive the market growth in the ... demand for antidepressants in the recent years. Continue ... ... ...
(Date:1/23/2017)... Spain , January 23, 2017 ... clinical-stage biopharmaceutical company focused on treatments for calcification ... been enrolled in the Phase IIb "CaLIPSO Study" ... treatment of cardiovascular calcification (CVC) in end-stage-renal-disease (ESRD) ... patients, in the last stage of chronic kidney ...
(Date:1/23/2017)... Just two weeks remain until legal experts and senior industry leaders involved ... London to discuss the flow of pharmaceutical products post Brexit ... Trade 2017 . In the run up to the show, ... to read in the event download centre . ... Some of those confirmed include: ...
Breaking Medicine Technology:
(Date:1/23/2017)... ... 23, 2017 , ... "ProRandom is a set of camera tools that allow video editors to ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , With ... with video footage. ProRandom works by using a virtual camera to create the illusion ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... (OREF), in partnership with the American Society of Anesthesiologists® (ASA®), the Foundation ... the American Academy of Orthopaedic Surgeons (AAOS) and the Cigna Foundation, encourages ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... “The Inn at the Mill”: a ... unexpected fears in her quest to become happy and content. , “The Inn at ... Pennsylvania, has also lived in Germany and Vermont and is now living in Berks County ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... and resources at seafoodnutrition.org/programs and seafoodnutrition.org/resources to assist in teaching communities and ... resources have been developed for use by nutrition educators and influencers within ...
(Date:1/23/2017)... ... ... Infallible Characteristics of Christ”: a fascinating and entrancing novel exploring the gifts and ... author, Rev. Dr. Robert W. Thomas, the third of seven siblings. He was a ... pastor for over fifteen years. He is a graduate of N.C. College of Theology ...
Breaking Medicine News(10 mins):